XML 30 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Redeemable Convertible Preferred Stock Beginning Balance (in shares) at Dec. 31, 2019 336,843,578          
Redeemable Convertible Preferred Stock Beginning Balance at Dec. 31, 2019 $ 335,748          
Redeemable Convertible Preferred Stock            
Issuance of Series E-1 redeemable convertible preferred stock (in shares) 20,989,756          
Issuance of Series E-1 redeemable convertible preferred stock $ 166,942          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (5,988,994)          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (809)          
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Dec. 31, 2020 351,844,340          
Redeemable Convertible Preferred Stock Ending Balance at Dec. 31, 2020 $ 501,881          
Balance at the beginning of the period (in shares) at Dec. 31, 2019     118,430,031      
Balance at the beginning of the period at Dec. 31, 2019 (198,406)   $ 12 $ 7,365 $ 46 $ (205,829)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)     5,988,994      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 809   $ 1 808    
Issuance of common stock upon exercise of vested options (in shares)     5,236,999      
Issuance of common stock upon exercise of vested options 2,472     2,472    
Repurchase of early exercised stock options (in shares)     (190,370)      
Issuance of common stock net settlement of restricted stock units (in shares)     847,184      
Vesting of early exercised stock options 742     742    
Vesting of common stock warrants 171     171    
Share-based compensation expense 28,211     28,211    
Change in accumulated other comprehensive income (loss) (21)       (21)  
Net loss (47,695)         (47,695)
Balance at the end of the period (in shares) at Dec. 31, 2020     130,312,838      
Balance at the end of the period at Dec. 31, 2020 $ (213,717)   $ 13 39,769 25 (253,524)
Redeemable Convertible Preferred Stock            
Deferred offering costs   $ 8,058        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (351,844,340)          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (501,881)          
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Dec. 31, 2021 0          
Redeemable Convertible Preferred Stock Ending Balance at Dec. 31, 2021 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon Initial public offering, net of issuance costs (in shares)     52,272,727      
Issuance of common stock upon initial public offering, net of issuance costs 1,312,338   $ 7 1,312,331    
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)     351,844,340      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 501,881   $ 34 501,847    
Reclassification of redeemable convertible preferred stock warrant liabilities to common stock and additional paid-in capital upon initial public offering 5,438     5,438    
Issuance of common stock upon exercise of vested options (in shares)     4,277,344      
Issuance of common stock upon exercise of vested options 4,969     4,969    
Issuance of common stock under employee stock purchase plan (in shares)     153,905      
Issuance of common stock under employee stock purchase plan 3,201     3,201    
Repurchase of early exercised stock options (in shares)     (85,870)      
Issuance of common stock net settlement of restricted stock units (in shares)     1,736,212      
Issuance of common stock upon net settlement of restricted stock units (23,552)     (23,552)    
Issuance of common stock upon exercise of common stock warrants (in shares)     872,022      
Issuance of common stock upon exercise of common stock warrants 60          
Vesting of common stock warrants 6,332     6,332    
Share-based compensation expense 142,660     142,660    
Change in accumulated other comprehensive income (loss) (2,255)       (2,255)  
Net loss (163,929)         (163,929)
Balance at the end of the period (in shares) at Dec. 31, 2021     541,383,518      
Balance at the end of the period at Dec. 31, 2021 $ 1,573,426   $ 54 1,993,055 (2,230) (417,453)
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Dec. 31, 2022 0          
Redeemable Convertible Preferred Stock Ending Balance at Dec. 31, 2022 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of vested options (in shares)     7,785,748      
Issuance of common stock upon exercise of vested options 9,754     9,754    
Issuance of common stock under employee stock purchase plan (in shares)     683,485      
Issuance of common stock under employee stock purchase plan 4,762     4,762    
Repurchase of early exercised stock options (in shares)     (45,958)      
Issuance of common stock net settlement of restricted stock units (in shares)     3,214,677      
Issuance of common stock upon net settlement of restricted stock units (15,362)     (15,362)    
Vesting of common stock warrants 8,621     8,621    
Share-based compensation expense $ 160,743     160,743    
Repurchase and retirement of common stock (in shares) (11,700,000)   (11,657,371)      
Repurchase and retirement of common stock $ (79,201)   $ 1 (79,200)    
Change in accumulated other comprehensive income (loss) (5,007)       (5,007)  
Net loss (184,780)         (184,780)
Balance at the end of the period (in shares) at Dec. 31, 2022     541,364,099      
Balance at the end of the period at Dec. 31, 2022 $ 1,472,956   $ 53 $ 2,082,373 $ (7,237) $ (602,233)